CRNA raises NOK 620 million, funding through 2030
CRNA raised NOK 620 million to fund circVec R&D and business development through 2030. The company cites circVec technology advances, including up to 60x improved in-vivo gene expression.
CRNA said major advances in circVec technology have lifted gene expression in vivo by up to 60x, with next-generation designs targeting a 200x improvement. The company said it raised NOK 620 million, securing funding through 2030 and enabling expanded R&D and business development. It added the funding positions the company as a leader in circular RN…